Dr. Wilbur Song joined the Department of Medicine in the Division of Oncology as an Instructor as of July 2025.
Dr. Song is interested in developing novel platforms for solid tumor immunotherapy, with a focus on biologics and cellular therapies. His work in the laboratory aims to generate therapeutic agents that can be advanced to preclinical models and ultimately to clinical trials in cancer patients.
He is also interested in maintaining a clinical practice seeing genitourinary oncology patients and leading clinical trials of novel immunotherapeutic and other agents for prostate cancer patients.